Acorda Therapeutics Inc (ACORQ)
0.70
-0.20
(-22.22%)
USD |
OTCM |
Apr 30, 16:00
Acorda Therapeutics Total Liabilities (Quarterly): 266.48M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 266.48M |
| September 30, 2023 | 307.39M |
| June 30, 2023 | 296.83M |
| March 31, 2023 | 297.95M |
| December 31, 2022 | 301.97M |
| September 30, 2022 | 317.57M |
| June 30, 2022 | 318.40M |
| March 31, 2022 | 296.59M |
| December 31, 2021 | 304.33M |
| September 30, 2021 | 301.61M |
| June 30, 2021 | 301.02M |
| March 31, 2021 | 377.77M |
| December 31, 2020 | 394.72M |
| September 30, 2020 | 396.92M |
| June 30, 2020 | 437.30M |
| March 31, 2020 | 447.15M |
| December 31, 2019 | 488.90M |
| September 30, 2019 | 598.57M |
| June 30, 2019 | 652.62M |
| March 31, 2019 | 667.35M |
| December 31, 2018 | 687.68M |
| September 30, 2018 | 712.46M |
| June 30, 2018 | 643.98M |
| March 31, 2018 | 637.15M |
| December 31, 2017 | 677.98M |
| Date | Value |
|---|---|
| September 30, 2017 | 665.07M |
| June 30, 2017 | 642.72M |
| March 31, 2017 | 643.72M |
| December 31, 2016 | 678.12M |
| September 30, 2016 | 651.60M |
| June 30, 2016 | 665.00M |
| March 31, 2016 | 527.68M |
| December 31, 2015 | 508.27M |
| September 30, 2015 | 525.39M |
| June 30, 2015 | 540.27M |
| March 31, 2015 | 549.96M |
| December 31, 2014 | 524.81M |
| September 30, 2014 | 449.85M |
| June 30, 2014 | 442.94M |
| March 31, 2014 | 161.37M |
| December 31, 2013 | 166.77M |
| September 30, 2013 | 160.26M |
| June 30, 2013 | 171.11M |
| March 31, 2013 | 173.78M |
| December 31, 2012 | 179.41M |
| September 30, 2012 | 164.99M |
| June 30, 2012 | 173.40M |
| March 31, 2012 | 166.96M |
| December 31, 2011 | 174.28M |
| September 30, 2011 | 164.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
266.48M
Minimum
Dec 2023
652.62M
Maximum
Jun 2019
373.90M
Average
317.57M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| BioSig Technologies Inc | 4.685M |
| Verve Therapeutics Inc | 153.19M |
| Spectral AI Inc | 10.88M |
| AIM ImmunoTech Inc | 9.147M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.52M |
| Shareholders Equity (Quarterly) | -157.96M |
| Debt to Equity Ratio | -1.178 |
| Current Ratio | 0.3284 |
| Net Debt Paydown Yield | 1.65% |